These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. The dystroglycan complex: from biology to cancer. Sgambato A, Brancaccio A. J Cell Physiol; 2005 Nov 01; 205(2):163-9. PubMed ID: 15920757 [Abstract] [Full Text] [Related]
32. Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex. Bozzi M, Sciandra F, Brancaccio A. Matrix Biol; 2015 Nov 01; 44-46():130-7. PubMed ID: 25701226 [Abstract] [Full Text] [Related]
33. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction. Kojima K, Davidovits A, Poczewski H, Langer B, Uchida S, Nagy-Bojarski K, Hovorka A, Sedivy R, Kerjaschki D. J Am Soc Nephrol; 2004 Aug 01; 15(8):2079-89. PubMed ID: 15284294 [Abstract] [Full Text] [Related]
35. alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. Montanaro F, Lindenbaum M, Carbonetto S. J Cell Biol; 1999 Jun 14; 145(6):1325-40. PubMed ID: 10366602 [Abstract] [Full Text] [Related]
36. Dystroglycan complex in cancer. Brennan PA, Jing J, Ethunandan M, Górecki D. Eur J Surg Oncol; 2004 Aug 14; 30(6):589-92. PubMed ID: 15256230 [Abstract] [Full Text] [Related]
38. Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. Sciandra F, Bigotti MG, Giardina B, Bozzi M, Brancaccio A. Biomed Res Int; 2015 Aug 14; 2015():635792. PubMed ID: 26380289 [Abstract] [Full Text] [Related]
39. Targeting dystroglycan in the brain. Montanaro F, Carbonetto S. Neuron; 2003 Jan 23; 37(2):193-6. PubMed ID: 12546815 [Abstract] [Full Text] [Related]